What's in Tasly Pharmaceuticals, Inc.'s pipeline?

Tasly Pharmaceuticals, Inc. has 9 drugs in our index: 1 marketed, 0 filed, 5 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Tasly Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Beijing Tiantan Hospital, AJU Pharm Co., Ltd., Aciex Therapeutics, Inc., Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tasly-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Tasly Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Tasly Pharmaceuticals, Inc. pipeline: 1 marketed, 0 filed, 5 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 5 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Compound danshen dripping pills	Compound danshen dripping pills	marketed	Traditional Chinese medicine preparation; antiplatelet/anticoagulant agent		Cardiovascular
5LGr	5LGr	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
T89 high dose	T89 high dose	phase 3	Traditional Chinese medicine compound / Herbal extract		Cardiovascular
T89 capsule	T89 capsule	phase 3	Herbal/Traditional medicine derivative; cardiac metabolic agent		Cardiovascular
T89 Low dose	T89 Low dose	phase 3	Traditional Chinese medicine compound		Cardiovascular
Sanqi+Bingpian	Sanqi+Bingpian	phase 3	Traditional Chinese medicine compound		Cardiovascular

Therapeutic area mix

Cardiovascular · 5
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Tiantan Hospital · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AO GENERIUM · 1 shared drug class
ADvantage Therapeutics · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tasly Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Tasly Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tasly-pharmaceuticals-inc. Accessed 2026-05-16.